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ABSTRACT 
Background 
General obesity is a risk factor for fibromyalgia (FM), especially in physically inactive 
women, while abdominal obesity is a recognized risk factor for, and a feature in several 
metabolic diseases. Women with FM have shown higher prevalence of metabolic syndrome 
compared to healthy women. However, whether FM and chronic musculoskeletal pain are 
associated with abdominal obesity, independent of concurrent general obesity, is unclear.  
Objective 
To examine the association between FM and severity of chronic musculoskeletal pain and, 1) 
general obesity (i.e., peripheral or overall body fat distribution) and, 2) abdominal obesity 
(i.e., central body fat distribution). In addition, the impact of physical exercise on these 
associations was investigated in supplementary analyses. 
Methods 
A cross-sectional study was conducted on levels of Body Mass Index (BMI) and measures of 
abdominal fat layers (i.e., Waist Circumference [WC], Waist-to-Hip ratio [WHR], and Waist-
to-Height ratio [WHtR]) in relation to the prevalence of FM in a large, unselected female 
population. First, healthy women and women with diabetes mellitus (DIA) and/or glucose 
level (GL) ≥11.1 mmol/l were used as references (n=28,788). Second, healthy women and 
women with localized chronic musculoskeletal pain were used as references (n=21,752). In 
analyses of influence of physical exercise, women with physical impairments were excluded 
(n=18,988). 
Results 
BMI and measures of abdominal fat layers showed positive associations to the prevalence of 
FM, DIA/GL ≥11.1 mmol/l, and FM with DIA/GL ≥11.1 mmol/l (P for trend <0.001), and 
dose-response relations to severity of chronic musculoskeletal pain (P for trend <0.001). 
Measures of abdominal fat layers were highly correlated with BMI in all subgroups. Women 
who reported highest exercise level had lowest BMI and measures of abdominal fat layers.  
Conclusion 
Both abdominal obesity (indicated by WC, WHR, and WHtR) and general obesity (indicated 
by BMI) showed a strong dose-response relation to severity of chronic musculoskeletal pain 
and FM. Physical exercise moderated these relations. Measures of abdominal fat layers were 
highly correlated with BMI, indicating that central body fat accumulation in women with FM 
and chronic musculoskeletal pain reflects concurrent overall body fat accumulation.  
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INTRODUCTION 
Fibromyalgia (FM) is a chronic pain syndrome, defined by widespread pain and reduced 
pressure pain threshold at 11 or more of 18 anatomically defined tender points sites
1
. Pain 
should have been present for the past 3 months or more, and should be experienced in all four 
body quadrants as well as the axial body
1,2
. The clinical picture of patients with FM displays a 
wide range of variations, including comorbid symptoms like anxiety, depression, fatigue
2-4
, 
cognitive deficits, headache
2,3
, and insomnia
2
. The overall prevalence of FM in a 
representative Norwegian county population was found to be 5.2% for females and 0.9% for 
men
4
. In addition, the prevalence seems to increase with age up to approximately 70 years
2
. 
The pathogenesis of FM is poorly understood, but data support features with a dysregulation 
of the stress response system, including deficiencies in the hypothalamic-pituitary-adrenal 
(HPA) axis
5-8 
and in the sympathetic nervous system (SNS)
5-7,9,10
, with further altered pain 
perception and reduced capacity for endogenous pain inhibition
6,7
. 
 
FM, obesity, and associated features 
Cross-sectional studies have found a higher prevalence of overweight and obesity among 
women with FM compared to healthy women
11-13
. Further, being overweight or obese is also 
associated with an increased risk of developing FM, especially in physically inactive 
women
14
. High Body Mass Index (BMI) is associated with some FM features, including poor 
sleep quality
11,15
, physical impairment
11-13
, and reduced pain pressure threshold and quality of 
life
13
. Conversely, weight loss among obese women with FM is associated with reduced pain 
and other FM related symptoms
16
. 
The prevalence of obesity has increased worldwide during the last decades
17,18
. It is 
well established that obesity has a major impact on the incidence of diseases like 
cardiovascular disease, diabetes mellitus type 2 (DIA), cancer, as well as physical 
disability
17,18
. Abdominal subcutaneous and visceral adipose tissue compartments exhibit 
physiological differences, whereby a high visceral fat layer is considered as a strong and 
independent risk factor for several metabolic diseases
19-23
. This association may be attributed 
to altered cortisol secretion and the high density of glucocorticoid receptors in visceral 
adipose tissue, together with inhibited sex steroids and growth hormones secretion leading to 
insufficient counteraction against cortisol effects 
21-25
. Further, the visceral adipose tissue has 
a close anatomical relation to the hepatic portal circulation, as well as a specific propensity to 
mobilize free fatty acids
19,22,23
. In addition to secretion of adipokines and other lipid and 
4 
 
vasoactive substances in adipose tissue
19,21,22
, this may then contribute to disturbances like the 
low-graded, systemic inflammatory state seen in obesity
19,21,26
 and thereby increased risk of 
chronic pain development
7,27
. 
Metabolic syndrome comprise a clustering of vascular risk factors, and may indicate 
an early stage of DIA, whereby both conditions are characterised by impaired glucose 
regulation and abdominal obesity
19,28
. Loevinger and co-workers (2007)
29
 reported increased 
prevalence of metabolic syndrome among women with FM, including higher prevalence of 
abdominal obesity measured as increased Waist Circumference (WC) and Waist-to-Hip ratio 
(WHR), compared to healthy controls. Since BMI or body mass did not differ significantly 
between women with FM and healthy controls, it was suggested that obesity in many women 
with FM
11-13
 may include a bias toward central adiposity
29
. 
Neuroendocrine disturbances, often following undue stress exposure, may lead to the 
development of metabolic syndrome
21,24,30,31
. In coherence with this, SNS activation and HPA 
axis dysregulation in FM
5-10
 have similarities to mechanisms which contribute to development 
of obesity in general, and visceral abdominal obesity in particular
21,22,24,30
. These disturbances 
may be seen as a dysfunction in the stress response system
5,6,21,22,24,32
, exemplified by altered 
cortisol secretion
7,8,33
 and increased sympathetic tonus and reduced sympathetic reactivity
7,9,10
 
reported in FM patients. Other chronic musculoskeletal pain conditions have been associated 
with the similar abnormalities as well, i.e., neuroendocrine disturbances
7,33
, a low-graded 
inflammatory state
7,27
, and total body fat accumulation
34,35
. 
The increased prevalence of obesity and related diseases is linked to the growing 
tendency of insufficient physical activity worldwide
17,36
.  It is well-known that regular 
physical exercise has both a primary and a secondary impact on obesity, and obesity-related 
diseases
17,37
, illustrated by its beneficial influence on physical fitness
37
, body fat
38,39
, and on 
immune and neuroendocrine perturbations
40-44
. Large-scale population-based studies have 
indicated associations between physical inactivity and increased risk of chronic 
musculoskeletal complaints
45
, including symptoms in neck/shoulders and low back
46
, as well 
as chronic widespread pain as observed in FM
14
.  Contrary, regular physical exercise may 
decrease comorbid symptoms of FM
47-49
, improve musculoskeletal health
37
, and facilitate 
control of a healthy body mass
38,39
. 
 
Measurements of total body fat and body fat distribution 
Different anthropometric measurements have different accuracy in estimating body fat 
distribution
50-52
 and total body fat mass
50,53
. Measurements of abdominal fat layers most often 
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measure abdominal visceral and subcutaneous fat compartments as an unity, since these fat 
depots need multi-compartment methods to be distinguish. Such methods are reliable, but the 
costs are high in terms of time and resources, and more easily detected measures are often 
more practical
50,54
. BMI is thought to have moderate accuracy to measure total body fat mass, 
but has difficulties in predicting body composition or body fat distribution
50,53,55
. WC or ratio 
measures as WHR or Waist-to-Height ratio (WHtR) are likely to indicate central versus 
peripheral fat distribution, despite the inability to distinguish between the abdominal 
subcutaneous and visceral fat layers
50
. Alone, WC has been shown to be more strongly 
correlated with the abdominal visceral fat compartment than the WHR
51,52
. 
 
Study objectives 
The main objective of the present study was to investigate the associations between the 
prevalence of FM, BMI and measures of abdominal fat layers in a large unselected population 
of adult women. A second objective was to investigate whether severity of chronic 
musculoskeletal pain is related to levels of BMI and measures of abdominal fat layers. In this 
analysis, severity of pain was expressed by number of chronic pain sites with FM as end point 
of the continuum. In additional analyses, it was investigated whether level of leisure time 
physical exercise influence the above mentioned relations. 
To address the objectives, a cross-sectional analysis was conducted on levels of BMI 
and measures of abdominal fat layers in relation to the prevalence of FM. In addition to using 
healthy women, and women categorized by number of pain sites as references, women with 
DIA and/or hyperglycemia were included as an additional subgroup. Based on the discussed 
associations between FM, metabolic disturbances, and central adiposity, the primary purpose 
of including this subgroup was to elucidate the relation between FM and body fat distribution, 
independent of these related metabolic comorbidities. Data from the Nord-Trøndelag Health 
Study (HUNT 2) were used, which is an ongoing, comprehensive, population-based health 
study in one of Norway’s 19 counties. 
 
 
MATERIALS AND METHODS 
Study population 
In Nord-Trøndelag County in Norway, all inhabitants ≥20 years have been invited to 
participate in three waves of a large health survey (the HUNT Study). The first survey was 
carried out in 1984-86 (HUNT 1), the second in 1995-97 (HUNT 2), and the third in 2006-08 
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(HUNT 3). The HUNT Study was approved by the Regional Committee for Ethics in Medical 
Research and has been carried out according to the Declaration of Helsinki. 
Among 46,709 eligible women, 34,751 accepted the invitation to HUNT 2. They filled 
out a questionnaire that was included with the invitation. The clinical examination included 
standardized measurements of body mass, body height, and circumference of waist and hip. 
The participants were given a second questionnaire to complete at home and return in a 
prestamped envelope. Briefly, information was collected on a range of lifestyle and health-
related factors, including level of physical exercise, musculoskeletal pain, and various 
diseases. Details of the HUNT study are described at www.hunt.ntnu.no/.  
 The first part of the analyses focus on associations between FM, metabolic 
disturbances (i.e., DIA and hyperglycemia), and different measures of body fat. In these 
analyses, 1,008 women were excluded due to missing data on waist and hip circumference, 
body mass and/or body height. Furthermore, 4,916 women were excluded due to missing data 
on FM and DIA status (3,734 women), pregnancy (276 women), or hypothyroidism (906 
women). Additionally, 39 women reported to have acquired diabetes before the age of 20 and 
were excluded from analyses (i.e., likely diabetes mellitus type 1). As a result, the first part of 
the analyses is based on data from 28,788 women.  
The second part of the analyses focus on associations between number of chronic pain 
sites, FM, and different measures of body fat. Women without measurement of waist and hip 
circumference, body mass and/or body height were excluded from the analyses (1,008 
women), as well as women with missing data on questions related to chronic musculoskeletal 
pain (8,018 women), and FM status (3,697 women). In addition, pregnant women were also 
excluded from the analyses (276 women). As a result, the second part of the analyses includes 
21,752 women.  
 In analyses concerning an association with physical exercise level, additional 2,764 
women were excluded due to reporting of moderate or severe physical impairments or due to 
missing data on physical exercise. As a result, analyses including physical exercise as an 
independent variable are based on data from 18,988 women. 
 
Study variables 
Body mass index and measures of abdominal fat layers 
BMI was calculated as body mass (in kg) divided by the square value of body height (in 
meters) obtained at the clinical examination. BMI was further subdivided into four categories 
based on the cut points suggested by the World Health Organization (WHO)
56
, i.e., ≤18.5 
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kg/m² (underweight), 18.6-24.9 kg/m² (normal weight), 25.0-29.9 kg/m² (overweight), ≥30.0 
kg/m² (obese). WC, WHR, and WHtR were used as measures of abdominal fat layers. 
Standardized measurements of waist and hip circumference (in cm) were obtained at the 
clinical examination. WHR was calculated as the WC (in cm) divided by the hip 
circumference (in cm), and WHtR was calculated as the WC (in cm) divided by the body 
height (in cm).  
 
Physical exercise 
Weekly average duration of leisure time physical exercise during the last year was assessed 
with two questions: 1) reporting of the number of hours of light activity (no sweating or being 
out of breath) per week, and 2) reporting of the number of hours of hard activity (sweating or 
being out of breath) per week. Travel to work was counted as leisure time physical exercise. 
Both questions allowed 4 response options (0, <1, 1-2 and ≥3 hours/week).  
Based on the information about frequency of light and hard activity, the participants 
were subdivided into categories of inactive to very low activity (<3 hours of light activity 
and/or 0 hour/week of hard activity) and low to high activity (≥3 hours of light activity and/or 
≥1 hours/week of hard activity).  
 
FM and chronic musculoskeletal pain 
Information on FM was obtained from the questionnaire, where the participants were asked to 
respond (yes/no) to the question “Have a doctor ever said that you have fibromyalgia 
(fibrositis/chronic pain syndrome)?”. Regarding chronic musculoskeletal pain the participants 
were asked to report whether they had suffered from musculoskeletal pain of at least 3 
months’ duration during the last year (yes/no) by the question: “During the last year, have you 
had pain and/or stiffness in your muscles and limbs that lasted for at least 3 consecutive 
months?”. If “yes”, they were asked to indicate pain localization, i.e., by ticking off one or 
several of the following nine body areas; neck, shoulders, elbows, wrist/hands, upper back, 
low back, hips, knees and/or ankles/feet. Based on number of pain sites, the participants were 
subdivided into four subgroups: 1) 0 pain sites/reporting no chronic musculoskeletal pain, 2) 
1-2 chronic pain sites, 3) 3-5 chronic pain sites, and 4) ≥6 chronic pain sites. 
 
Diabetes and hyperglycemia 
The presence of DIA was measured by the question “Do you have, or have you ever had, 
diabetes?” with the response options “yes” or “no”. In addition, women demonstrating 
8 
 
increased glucose level (GL) were included in the same subgroup. This inclusion was owed to 
the relation between DIA and obesity
19,22
 and the report of high prevalence of metabolic 
syndrome among women with FM
29
, together with different severity of impaired glucose 
regulation
57
. Hyperglycemia may indicate an early stage of DIA, and is a metabolic 
disturbance whereby excess abdominal body fat is likely
28
. Measurement of non-fasting GL 
was obtained with a venous blood sample at the clinical examination. The present study 
defines hyperglycemia as a random GL of ≥11.1mmol/l. This is a recommended cut-point for 
2-hours oral glucose tolerance test in the diagnosing of DIA
57
, and is previously used as a 
boundary for random glucose test in the determination of prevalence of DIA and 
hyperglycemia
58
.  
 
Statistical analyses 
In the first part of the analyses, based on the information on FM, DIA, and GL, the 
participants were subdivided into four groups reflecting their pathological status: 1) reporting 
neither DIA and/or GL ≥11.1 mmol/l, nor FM (healthy), 2) reporting FM without DIA and/or 
GL ≥11.1 mmol/l (FM), 3) reporting DIA and/or GL ≥11.1 mmol/l without FM (DIA/GL), 
and 4) reporting both FM and DIA and/or GL ≥11.1 mmol/l (FM/DIA/GL). 
Data were assessed using descriptive statistics. The distribution of variables across the 
different subgroups was analyzed using crosstabs. Mean and standard deviation of measures 
across the different subgroups were analyzed using frequencies. A general linear regression 
was applied to estimate mean differences with 95% confidence interval (CI) in BMI and 
measures of abdominal fat layers (i.e., WC, WHR, and WHtR as dependent variables) 
between the different subgroups. Potentially confounding factors were included in multiple 
linear regression analyses separately and together. Potentially confounding factors were age 
(10 years categories), smoking (never, former, current, unknown), leisure time physical 
exercise (low to high activity, inactive to very low activity, unknown), parity (no births, 1 
birth, ≥2 births, unknown), education (<10 years, 10-12 years, ≥13 years, unknown), and 
psychological well-being (depressed, somewhat happy, happy, unknown), and all final 
analyses were adjusted for these factors. Trend tests across subgroups of FM, DIA, and GL, 
and of chronic pain affliction were done by threating the subgroups as ordinal variables in 
multiple linear regression analyses.  
Distributions of comorbidities (i.e., athrosis, fatigue, insomnia, and functional 
restraining pain, illnesses or injuries) across the subgroups were analyzed using crosstabs. To 
evaluate whether levels of BMI and measures of abdominal fat layers among women in the 
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subgroups of FM and DIA/GL ≥11.1 mmol/l were independent of each other, additional 
general linear regression analyses were done, where crude measures of abdominal fat layers 
(i.e., WC and WHR) and BMI among healthy women and women in the subgroup of FM, 
DIA/GL, or FM/DIA/GL were compared. We conducted stratified (low to high activity vs. 
inactive to very low activity) analyses to evaluate the effect of physical exercise on the 
relations between number of chronic pain sites/FM, and BMI and measures of abdominal fat 
layers. Statistical analyses were done as in the main part, but without adjusting for leisure 
time physical exercise in the final analyses. To evaluate whether other conditions could affect 
the results of the second part, supplementary analyses were done. In addition to the primary 
excluding factors, women reporting other chronic diseases (i.e., DIA, osteoporosis, 
rheumatoid arthritis, arthrosis, morbus Bechterew, hypothyroidism, or the collective term 
“other long-term diseases”) were excluded, and the same statistical analyses as in the main 
part were then done. P <0.001 was considered as statistical significant in all estimates. All 
statistical analyses were carried out using SPSS statistics (version 17.0). 
 
 
RESULTS 
Associations between FM, metabolic disturbances and body fat  
Participant characteristics according to BMI are presented in Table 1.  
 
Table 1. Participant characteristics categorized by body mass index*. Percentages are presented as proportions 
of study population for the subgroups, and as proportion within categories for remaining variables. 
 Underweight Normal weight Overweight Obese 
Age, mean (SD) 43.4 (19.7) 43.9 (15.8) 51.1 (16.4) 54.2 (16.4) 
Women, % (no.) 1.1 (307) 45.5 (13,103) 36.0 (10,377) 17.4 (5,001) 
   Healthy
a
, % (no.) 1.1 (287) 46.9 (12,235) 35.8 (9,349) 16.2 (4,226) 
FM, % (no.) 1.0 (16) 34.4 (571) 39.5 (655) 25.2 (418) 
DIA/GL, % (no.) 0.4 (4) 29.8 (288) 35.6 (345) 34.2 (331) 
FM/DIA/GL, % (no.) 0.0 (0) 14.3 (9) 44.4 (28) 41.3 (26) 
Inactive
b
,% (no.) 41.0 (126) 34.6 (4,531) 40.3 (4,178) 47.2 (2,361) 
Smoking
c
, % (no.) 50.8 (156) 34.9 (4,578) 26.5 (2,755) 22.1 (1,103) 
Higher educ.
d
, % (no.) 33.2 (102) 39.6 (5,189) 26.7 (2,773) 17.6 (880) 
Depressed, % (no.) 3.9 (12) 3.2 (425) 3.0 (315) 3.0 (151) 
Parity, mean (SD) 2.5 (1.3) 2.4 (1.4) 2.4 (1.4) 2.4 (1.4) 
WC, mean (SD) 64.5 (4.4) 73.1 (5.9) 83.5 (6.7) 97.5 (9.4) 
WHR, mean (SD) 0.74 (0.05) 0.77 (0.05) 0.81 (0.05) 0.84 (0.06) 
WHtR, mean (SD) 0.39 (0.03) 0.44 (0.04) 0.51 (0.04) 0.60 (0.06) 
Abbreviations: FM = fibromyalgia without diabetes and/or glucose level ≥11.1mmol/l; DIA/GL = diabetes and/or 
glucose level ≥11.1mmol/l without fibromyalgia; FM/DIA/GL = fibromyalgia and diabetes and/or glucose level 
≥11.1mmol/l; WC = waist circumference; WHR = waist-to-hip ratio; WHtR = waist-to-height ratio 
*According to the cut points suggested by the World Health Organization  
a
Healthy defined as those who reported no fibromyalgia or diabetes and/or glucose level ≥11.1 mmol/l 
b
Inactive to very low activity 
c
Current smoker 
d
Reported an education of ≥13 years 
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Mean age increased along with increasing BMI. Most women in the study population were 
normal weight. Among the different subgroups, healthy women showed highest percentage of 
normal weight, whereas percentages of overweight and obese increased with FM, DIA/GL, 
and were highest in the FM/DIA/GL subgroup. Measures of abdominal fat layers (i.e., WC, 
WHR, and WHtR) increased with BMI. Percentages of current smokers decreased with 
increasing BMI. Apart from the category of underweight, percentages of women with higher 
education showed a similar trend, whereas percentages of inactive increased. The proportions 
of depression and parity were similar across BMI categories. 
 
Table 2. Mean and mean difference (MD) of body mass index (BMI) and waist circumference (WC) between 
healthy women, and women with fibromyalgia (FM), diabetes and/or glucose level ≥11.1 mmol/l (DIA/GL), and 
fibromyalgia/diabetes and/or glucose level ≥11.1 mmol/l (FM/DIA/GL). 
 
No. of 
women Mean value (SD) Crude MD 
Multi-adjusted
b
 
MD (95% CI) P trend 
BMI, kg/m
2
      
   Healthy
a
 26,097 25.9 (4.4) 0.0 0.0 (Reference)  
   FM 1,660 27.3 (4.8) 1.3 0.9 (0.7-1.2)  
   DIA/GL  968 28.5 (5.7) 2.5 1.8 (1.5-2.0)  
   FM/DIA/GL 63 30.0 (5.0) 4.0 3.1 (2.0-4.2) <.001 
      
WC, cm      
   Healthy
a
 26,097 80.5 (11.1) 0.0 0.0 (Reference)  
   FM 1,660 84.2 (11.8) 3.7 2.4 (1.8-2.9)  
   DIA/GL 968 87.9 (13.9) 7.3 4.8 (4.1-5.5)  
   FM/DIA/GL 63 91.2 (12.8) 10.7 7.7 (5.1-10.3) <.001 
a
Healthy defined as those who reported no fibromyalgia or diabetes and/or glucose level ≥11.1 mmol/l 
b
Adjusted for age (20-29, 30-39, …, ≥70 years), physical exercise (low to high activity, inactive to very low activity, 
unknown), smoking (never, former, current, unknown), education (<10 years, 10-12 years, ≥13 years, unknown), 
parity (0, 1, ≥2, unknown), psychological well-being (depressed, somewhat happy, happy, unknown) 
 
 
 
Table 2 presents mean values and adjusted mean differences of BMI and WC between healthy 
women, and women in the subgroups of FM, DIA/GL, and FM/DIA/GL. According to cut 
points of BMI, mean values for both healthy women, and women in the FM and DIA/GL 
subgroups were within the category of overweight (i.e., 25.0-29.9 kg/m²). Mean value for 
FM/DIA/GL subgroup were within the category of obese (i.e., ≥30.0 kg/m²). 
Correspondingly, both BMI and WC increased significantly in a dose-response manner 
between FM, DIA/GL, and FM/DIA/GL, referencing healthy women (P trend <.001). Using 
WHR or WHtR as measure of abdominal fat layers resulted in same trends with mean 
differences increasing significantly across the subgroups (P trend <.001 for both measures), 
i.e., the FM/DIA/GL subgroup showed the largest difference from healthy women (results not 
shown). 
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Associations between chronic musculoskeletal pain and body fat  
Table 3 presents participants characteristics according to number of chronic pain sites and 
FM. Women with ≥6 pain sites and women with FM tended to be older than healthy women 
and women with ≤5 pain sites. The percentage of women with higher education decreased 
with increasing number of pain sites/FM, whereas the percentages of women who reported to 
be inactive, current smoker, and depressed increased with increasing level of pain affliction.  
 
Table 3. Participant characteristics categorized according to number of chronic pain sites, and fibromyalgia (FM). 
Percentages are proportions within categories.  
 Healthy
d
 1-2 pain sites 3-5 pain sites ≥6 pain sites FM 
Women, no. 15,329 1,544 1,964 1,145 1,770 
Age, mean (SD) 45.4  (17.2) 47.7  (17.3) 49.1  (16.5) 52.4  (16.0) 52.1  (12.1) 
Inactive
a
, % (no.) 34.5  (5,296) 40.4  (624) 41.6  (818) 49.3  (564) 47.5  (840) 
Smoking
b
, % (no.) 26.8  (4,109) 28.9  (446) 35.0  (668) 39.8  (456) 41.2  (729) 
Higher educ.
c
, % (no.) 37.3  (5,718) 34.1  (526) 27.2  (535) 18.7  (214) 16.0  (284) 
Depressed, % (no.) 1.9  (294) 2.8  (44) 4.7  (93) 4.6  (53) 8.2  (145) 
Parity, mean (SD) 2.4  (1.4) 2.4  (1.5) 2.3  (1.4) 2.4  (1.6) 2.3  (1.4) 
a
Inactive to very low activity 
b
Current smoker 
c
Reported an education of ≥13 years 
d
Healthy defined as those who reported no musculoskeletal pain 
 
Mean values and mean differences of BMI and WC between healthy women, women with 
different number of pain sites, and women with FM are presented in Table 4. Both BMI and 
WC increased significantly in a dose-response manner with increasing level of pain affliction, 
referencing healthy women (P for trend <.001).  
 
Table 4. Mean and mean difference (MD) of body mass index (BMI, upper panel) and waist circumference (WC, 
lower panel) between categories with different pain affliction, i.e., healthy women, women with 1 to ≥6 chronic 
pain sites, and fibromyalgia (FM). 
Categories of pain 
affliction 
No. of 
women 
BMI, kg/m
2
,  
mean (SD) 
Crude 
MD 
Multi-adjusted
b
 MD 
(95% CI) 
 
P trend 
Healthy
a
 15,329 25.6 (4.3) 0.0 0.0 (Reference)  
1-2 1,544 26.1 (4.5) 0.5 0.4 (0.2-0.7)  
3-5 1,964 26.6 (4.8) 1.1 0.9 (0.7-1.1)  
≥6 1,145 26.9 (5.0) 1.4 0.9 (0.7-1.2)  
FM 1,770 27.4 (4.9) 1.8 1.3 (1.0-1.5) <.001 
      
Categories of pain 
affliction 
No. of 
women 
WC, cm,  
mean (SD) 
Crude 
MD 
Multi-adjusted
b
 MD 
(95% CI) 
 
P trend 
Healthy
a
 15,329 79.5 (10.8) 0.0 0.0 (Reference)  
1-2 1,544 81.5 (11.3) 2.1 1.6 (1.1-2.2)  
3-5 1,964 82.8 (12.0) 3.3 2.5 (2.0-3.0)  
≥6 1,145 84.0 (12.6) 4.6 2.9 (2.2-3.5)  
FM 1,770 84.5 (12.0) 5.0 3.2 (2.6-3.7) <.001 
a
Healthy defined as those who reported no musculoskeletal pain 
b
Adjusted for age (20-29, 30-39, …, ≥70 years), physical exercise (low to high activity, inactive to very low active, 
unknown), smoking (never, former, current, unknown), education (<10 years, 10-12 years, ≥13 years, unknown), 
parity (0, 1, ≥2, unknown), psychological well-being (depressed, somewhat happy, happy, unknown) 
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Using WHR or WHtR as measure of abdominal fat layers resulted in same trends with mean 
differences increasing significantly across subgroups (P trend <.001 for both measures), i.e., 
the FM subgroup showed the largest difference from healthy women (results not shown).  
 
Influence of physical exercise on chronic musculoskeletal pain and body fat  
Participant characteristics categorized by level of physical exercise are presented in Table 5. 
Women reporting lowest physical exercise level were on average oldest, exhibit highest mean 
values of BMI and measures of abdominal fat layers (i.e., WC, WHR, and WHtR), and 
reported highest percentages of current smokers and depressed, as well as lowest percentage 
of higher education. The percentages of women with no or very low activity increased with 
increasing number of pain sites/FM. 
 
Table 5. Participant characteristics categorized according to level of physical exercise. Percentages are 
presented as proportions of study population for the subgroups, and as proportion within categories for remaining 
variables. 
 Low to high activity Inactive to very low activity 
Age, mean (SD) 41.6 (14.9) 48.9 (16.1) 
Healthy
a
, % (no.) 62.6 (8,669) 37.4 (5,173) 
Pain afflication, 1 to ≥6 pain sites, % (no.) 56.9 (2,201) 43.1 (1,668) 
             1-2 pain sites, % (no.) 58.3 (803) 41.7 (574) 
             3-5 pain sites, % (no.) 58.1 (966) 41.9 (697) 
              ≥6 pain sites, % (no.) 52.1 (432) 47.9 (397) 
FM, % (no.) 48.6 (621) 51.4 (657) 
Smoking
b
, % (no.) 27.5 (3,165) 33.4 (2,506) 
Higher educ.
c
, % (no.) 45.1 (5,184) 25.0 (1,877) 
Depressed, % (no.) 2.5 (286) 3.3 (246) 
Parity, mean (SD) 2.4 (1.4) 2.4 (1.4) 
BMI, mean (SD) 25.3 (4.1) 26.4 (4.7) 
WC, mean (SD) 78.3 (10.3) 82.1 (11.6) 
WHR, mean (SD) 0.78 (0.06) 0.80 (0.06) 
WHtR, mean (SD) 0.47 (0.06) 0.50 (0.07) 
Abbreviations: FM = fibromyalgia; BMI = body mass index; WC = waist circumference; WHR = waist-to-hip ratio; 
WHtR = waist-to-height ratio 
a
Healthy defined as those who reported no musculoskeletal pain 
b
Current smoker 
c
Reported an education of ≥13 years 
 
 
Figure 1 presents the combined effect of physical exercise and chronic musculoskeletal pain 
on multi-adjusted mean values of BMI (A) and WC (B). Overall, the most active women had 
lower BMI and WC than the least active women across all pain categories. Physical exercise 
showed curved linear relations between level of pain affliction, and BMI and WC among 
women at both activity levels. The subgroup of FM tended to have highest differences in 
mean BMI and mean WC between the different levels of physical exercise. Moreover, women 
with FM who were inactive or had a very low activity level had a markedly higher BMI and 
WC than women in the same exercise category without FM. 
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Figure 1. Multi-adjusted mean values of body mass index (BMI) and waist circumference (WC) between levels of 
physical exercise, categorized by number of chronic pain sites, and fibromyalgia (FM). Error bars indicate 95% CI. 
Values are adjusted for age (20-29, 30-39, …, ≥70 years), smoking (never, former, current, unknown), education 
(<10 years, 10-12 years, ≥13 years, unknown), parity (0, 1, ≥2, unknown), psychological well-being (depressed, 
somewhat happy, happy, unknown). 
 
 
Using WHR or WHtR as measure of abdominal fat layers resulted in same trends as using 
WC (P trend <.001 for both comparisons) (results not shown).  
 
Correlation between BMI and WC 
A scatter plot showing the associations between crude BMI and WC within healthy women, 
women in the subgroups of FM, DIA/GL, and FM/DIA/GL are presented in Figure 2A. 
Separate regression lines for women in the different subgroups are shown in Figure 2B.  
 
 
Figure 2. Scatter plot of the association between crude waist circumference (WC) and body mass index (BMI) 
among healthy women and women with fibromyalgia (FM), diabetes and/or glucose level ≥11.1 mmol/l (DIA/GL), 
and fibromyalgia/diabetes and/or glucose level ≥11.1 mmol/l (FM/DIA/GL) (figure 2A). Separate regression lines 
are shown for women in the different subgroups (indicated by arrows) (figure 2B). 
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The slopes of the regression lines were 2.13 cm for women with FM, and 2.18 cm for healthy 
women, and women in DIA/GL and FM/DIA/GL subgroups (figure 2B), indicating a similar 
body fat distribution within the different subgroups, and a high correlation between BMI and 
WC. Using WHR as measure of abdominal fat layers resulted in same trends as using WC 
(result not shown). 
 
Distribution of comorbidities among women with FM 
Table 6 presents the percentages of comorbidities among women with FM, categorized by 
level of physical exercise. Women with FM who were inactive or had a very low activity 
level, reported highest percentages of insomnia, fatigue, arthrosis, pain which reduces leisure 
time activity or working capacity, and of other long-term illnesses or injuries that impair 
everyday function. It should be noted that the percentages reflect different responding rate 
across exercise levels and across measured comorbidities.  
 
Table 6. Percentage of comorbidities among women with fibromyalgia, categorized according to level of physical 
exercise. 
 Low to high activity Inactive to very low activity 
Insomnia, % (no.) 27.3  (169) 31.8  (209) 
Fatigue, % (no.) 10.9  (68) 14.0  (92) 
Reduced leisure time activity, % (no.) 81.4  (505) 88.0  (578) 
Considerably reduced working capacity
 
, % (no.) 42.1  (261) 50.4  (331) 
Long-term illness or injury
a
, % (no.) 62.5  (388) 65.2  (428) 
Arthrosis, % (no.) 24.0  (149) 30.6  (201) 
a
Illness or injury of physical or psychological nature that impairs everyday function 
 
 
DISCUSSION  
The main objective of the present study was to investigate the associations between FM, BMI, 
and measures of abdominal fat layers. A second objective was to investigate whether severity 
of chronic musculoskeletal pain (i.e., defined by number of pain sites/FM) are related to levels 
of BMI and measures of abdominal fat layers. Additionally, it was investigated whether level 
of leisure time physical exercise may influence the above mentioned relations. 
The analyses revealed positive associations between prevalence of FM, and levels of 
BMI and measures of abdominal fat layers. These associations were further independent of 
metabolic comorbidities of DIA or GL ≥11.1mmol/l, and the presence of FM together with 
one or both of these conditions resulted in even higher BMI and measures of abdominal fat 
layers. When examining the independent associations between prevalence of FM, DIA and/or 
GL ≥11.1mmol/l, and FM and DIA and/or GL ≥11.1mmol/l together, and measures of 
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abdominal fat layers or BMI, these associations showed no differences in body fat 
distribution, i.e., BMI and measures of abdominal fat layers increased in concurrence with 
each other in all subgroups.   
Results also indicated dose-response relations between number of chronic pain sites, 
with FM as the extreme endpoint, and levels of BMI and measures of abdominal fat layers. 
Also here, high measures of abdominal fat layers within FM reflected concurrent high BMI. 
Assessing effect of physical exercise, these relations showed curved linear relations to number 
of chronic pain sites among women without FM, as the women with ≥6 pain sites tended to 
have lower or similar BMI and measures of abdominal fat layers, compared to women with 3-
5 pain sites at the same activity level. Physical exercise moderated the dose-response 
associations, as women reporting the highest activity level in each subgroup had lowest BMI 
and measures of abdominal fat layers. This effect was particularly pronounced within the FM 
subgroup. 
Given the cross-sectional design of the study, causalities cannot be inferred. However, 
chronic widespread pain is thought to be best represented as a continuum from localized to 
more generalized pain
7,59
, whereby FM represent the severe end
7
. Then, the subgroups with 
different numbers of chronic pain sites can indicate different cross-sections of a continuum of 
chronic pain. Additionally, previous prospective
46,60,61 
and cross-sectional studies
15,34,35,61
 have 
reported positive associations between level of BMI, and the risk of and/or presence of pain 
and pain severity, including within FM patients
13,14
. Conversely, weight loss in women with 
FM seems to reduce pain
16
. A causal and linear relation between level of overall body fat 
accumulation and severity of chronic pain may then be hypothesized. Moreover, FM has been 
associated with higher prevalence of metabolic syndrome
29
, and increased prevalence of FM 
is reported among DIA patients
62
. Metabolic syndrome may indicate an early stage of DIA, 
with impaired glucose regulation and abdominal obesity (i.e., WC  ≥80cm among European 
women) acknowledged as important features of both conditions
19,28
. It is then possible that the 
subgroups of FM, DIA/GL, and FM/DIA/GL may indicate different cross-sections of a 
continuum with increasing involvement of metabolic disturbances. Accordingly, high BMI 
and/or abdominal fat layers has been reported as a risk factor for musculoskeletal pain
46,60,61
, 
FM
14
, and DIA
18,19,22
.  
 
FM, metabolic disturbances, and body fat distribution  
Increased prevalence of metabolic syndrome has been reported among women with FM, 
including higher abdominal fat layers measured as increased WC and WHR, compared to 
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healthy controls
29
. Since BMI or body mass did not differ significantly between women with 
FM and healthy controls, Loevinger and co-workers (2007)
 29
 suggested that obesity in many 
women with FM
11-13
 may reflect a bias toward central adiposity. 
Based on the current findings, an independent association between FM and abdominal 
obesity is questioned as WC and WHR were highly correlated with BMI among women in the 
subgroups of FM and FM/DIA/GL. Further, the similar correlation within and between all 
subgroups of FM and DIA/GL ≥11.1mmol/l is noteworthy, since a strong relation between the 
pathophysiology of DIA and hyperglycemia, and centralization of body fat has been indicated
 
19,22,23,28
. Thus, independent body fat centralization does not seem to be a pathological feature 
of either FM, DIA and/or GL ≥11.1mmol/l, or the combination of these conditions, but rather 
reflects concurrent presence of overweight or obesity in general. 
 
Chronic musculoskeletal pain, body fat, and related pathophysiological concomitants 
Despite the precluded possibility to draw conclusions regarding causations, possible 
explanations of the current findings may be suggested. First, the mechanical forces on the 
weight-bearing joints will increase as a consequence of increasing body mass, which further is 
related to load-related chronic pain as back pain
15,34,46,60
. Together with the reports from 
Loevinger
29
, there are findings of associations between high BMI and pain in nonweight-
bearing body sites
34,35,61
, and of a complex interplay between high BMI, pain, and FM 
comorbidities
11-13,15,16,59
. It is then likely that other pathophysiological mechanisms related to 
body fat accumulation overlap with those of pain and metabolic diseases. Among these, 
perturbations of the immune and neuroendocrine systems have to be considered. 
 
Neuroendocrine perturbations 
HPA axis dysregulation is assumed to be a feature in the pathogenesis of FM, with negative 
impact on pain perception and pain inhibition
5-8
. Further, this feature is tightly related to SNS 
activation and to a dysfunction in the stress response system
5-7,9,21,32,33
. Such dysregulation is 
thought to be part of the pathogenesis of other pain states as well, indicated by alteration of 
the physiologic responses required for adequate stress management and pain inhibition
6-7
. 
Finally, similar mechanisms are suggested to have an adverse impact on body fat 
accumulation, and on the development of metabolic disturbances like metabolic syndrome 
and DIA
21,22,24,30,31
. 
HPA axis dysregulation includes aberrant glucocorticoid signaling, and abnormal 
cortisol secretion is reported in obesity
22,25
, as well as in other conditions of a dysfunctional 
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stress response system like chronic pain states and FM
5,7,8,32,33
, and metabolic syndrome
21,24,31
. 
Prolonged increase in circulating glucocorticoids is related to higher energy 
intake/expenditure ratio, thereby increasing the probability of developing obesity and 
metabolic disturbances
21,24
. Accordingly, there are indications of close relations between HPA 
axis dysregulation, and increased BMI and/or abdominal fat layers
21,24
, including in FM
11
, 
despite seeming incongruous reports regarding the pattern of abnormal glucocorticoids 
secretion. Additionally, also dysautominia in FM
7,9,10
 shows similarities to disturbances which 
likely promote positive energy ratio and development of obesity and metabolic syndrome
30,31
 
 
Low-graded, systemic inflammation 
Obesity has been referred to as an unconventional type of low-graded, systemic inflammatory 
state, with marked changes in the secretion functions of adipocytes and macrophages, and 
with elevated serum concentrations of inflammatory markers
19,21,26
. Likewise, chronic 
musculoskeletal pain
7,27 
and FM
40,63
 display signs of inflammatory conditions. It has even 
been hypothesized that the origin of all pain is inflammation and the inflammatory response
64
, 
including inflammatory hypothesis of pain syndromes like FM
65
. SNS activation and 
disturbances of the HPA axis are closely associated with prolonged secretion and increased 
circulating levels of proinflammatory cytokines
21
. Elevated release of neurotransmitter 
substance P is thought to stimulate release of proinflammatory cytokines closely related to 
pain and FM
7,27,40,63,65
, and may contribute to an up-regulation of painful stimuli and lead to 
widespread pain
2,5,64
. Proinflammatory cytokines have been found to induce or facilitate both 
inflammatory and neuropathic pain as well as hyperalgesia
27,40
 and increased pain intensity in 
FM patients
63
. Several of these cytokines have been associated with obesity, metabolic 
syndrome, DIA, and chronic stress with derangement of the metabolic equilibrium
21,31,32,41
. 
Further, they have been associated with the presence of comorbid symptoms of FM like 
fatigue, depression, and sleep alterations
32,65
. Previous reports
21
, including findings among 
FM patients
11
, show relations between increasing circulating levels of inflammatory markers 
and accumulation of body fat. These reports may then substantiate the present associations 
between low-graded, systemic inflammation, obesity, chronic pain, and metabolic 
disturbances. 
Taken together, obesity has been recognized to be a disease of energy regulation, 
rather than a simple consequence of a disadvantageous lifestyle
22,25,26,30
. Beside energy 
consumption, accumulation of body fat is likely dependent on the energy intake, which is 
further thought to be regulated by a complex interplay between factors as cytokines, insulin, 
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and several neurotransmitters
 22,25,26,30
. Similarly, metabolic syndrome and DIA
21,22,24,30-32,41
, 
as well as chronic pain and FM
6,7,27,32,33
 are related to disturbances in the same interplay. 
Then, the current findings that increased body fat accumulation is associated with the 
presence of chronic musculoskeletal pain, FM, and DIA/GL ≥11.1mmol/l, are likely to partly 
be explained by common pathophysiological mechanisms of disturbances in the immune and 
neuroendocrine systems. 
Furthermore, it has been proposed that these abnormalities are associated with 
accumulation of the abdominal visceral fat compartment in particular
20-25,30
. The anatomical 
location of the visceral adipocytes and their drainage by the portal vein system have been 
suggested to be critical
19,23
. This, in combination with their innate capacity to mobilize free 
fatty acids, and the secretion of inflammatory markers and other lipid and vasoactive 
substances in adipose tissue
 
may then contribute to the relation
19,21-23
. In addition, altered 
cortisol secretion and the high density of glucocorticoid receptors in visceral adipose tissue, 
together with inhibited sex steroids and growth hormones secretion may lead to insufficient 
cortisol counteraction
21-25
. However, based on the present results, the idea needs further 
elucidation. Despite this view of the abdominal visceral fat layer as a relative high-risk fat 
depot, it amounts to only a lesser extent of the total adipose tissue mass
54,66
. Contrary, the 
abdominal subcutaneous fat compartment has a higher fat storage capacity, and the absolute 
risk attributed to this fat depot may then be greater
66
. Therefore, the question whether the 
effects of abdominal visceral and subcutaneous fat compartments actually differ in risk 
contributions may be ambiguous
20,25,50,54,66
. Similar, there are inconsistent reports regarding 
whether measures of abdominal fat layers (e.g., WC or WHR) are better, or make an 
additional contribution in the prediction of conditions related to the above-discussed 
disturbances
22,50,67-69
, compared to measures of overall body fat (such as BMI)
70-72
. 
The current associations did not exhibit any relation to increased measures of 
abdominal fat layers independent of concurrent increased BMI. However, the measures do not 
reflect the independent contribution of each abdominal fat compartment. The linear relation 
between BMI and measures of abdominal fat layers within all study groups may then include 
bias toward different contributions of the subcutaneous and visceral fat layers between and/or 
within the subgroups. Therefore, future studies must be conducted to state whether a high 
abdominal visceral fat layer is an independent phenomenon in any of the subgroups, and/or 
whether such an increase has an additional risk enhancing beyond a high abdominal 
subcutaneous fat layer or general obesity. However, it can be suggested that neither central fat 
19 
 
accumulation nor peripheral fat accumulation are independent features of the examined 
conditions, but rather presence together. 
 
Influence of physical exercise on body fat and chronic musculoskeletal pain 
Previous studies have reported that regular, well-adjusted physical exercise can improve 
tender-point pain threshold and reduce pain in FM and other inflammatory states
40,47,48
. 
Conversely, inactivity increases the risk of chronic musculoskeletal pain
45,46
 and FM
14
. 
The present study design prevents interference about causality, and the directionality 
of the relation between physical exercise and pain affliction cannot be determined. Regarding 
influence on body fat, the most active women within each subgroup had markedly lower BMI 
and measures of abdominal fat layers, compared to the least active. These findings imply a 
reverse impact of physical exercise on rate of body fat accumulation. Regular physical 
exercise has shown to affect body composition reflected by lower abdominal fat layers
38,39
 
and improved weight control
39
. Contrary, obesity may lead to inactivity
36
. Thus, differences in 
BMI and measures of abdominal fat layers between the most and the least active women in 
the current study may reflect impact on energy regulation brought about by exercise, and/or a 
restraining effect of overweight or obesity on exercise participation. However, a healthy body 
composition is likely to include more appropriate mechanical forces on weight-bearing joints 
and thereby lesser extent of load-related pain.  
Moreover, since obesity may reflects a pathological process as well
22,25,26,30
, it is likely 
that physical exercise influences pathophysiological resemblances of the investigated 
conditions. Independent reverse relation between level of physical exercise and degree of low-
graded, systemic inflammation has been suggested
42
. Initially, exercise enhance production of 
inflammatory substances, whereby increasing circulating levels of anti-atherogenic and anti-
inflammatory cytokines then restrict this inflammatory response by inhibition of 
inflammatory substances, inducing lipolysis and increasing fat oxidation
40-43
. Additionally, 
exercise training has the ability to modify regulation of the autonomic nervous system activity 
through increased parasympathetic tone, and decreased SNS activity
43,44
. Together, these 
events might also suppress appetite
26
. 
Thus, physical exercise may act directly on the pathophysiological features of chronic 
musculoskeletal pain, FM, and morbid body fat accumulation. The exact effect is likely to 
depend on type, frequency, duration and/or intensity of exercise
37,42,47,48
, and on individual 
factors such as physical fitness
37
 and disease characteristics
40,44,47
. 
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Exercise effect within the FM group 
The effect of physical exercise was particularly pronounced within the FM group. Differences 
in mean BMI and mean WC between the physical exercise levels in the three pain sites groups 
were 0.8 kg/m
2
 and 2.1-2.8 cm, whereas FM showed differences of 1.4 kg/m
2
 and 4.1 cm, 
respectively.  
FM represents a complex pain syndrome, with several subgroups regarding 
comorbidities and pathological mechanisms
2-4,73
. Despite likely benefits of physical 
exercise
40,47-49
, the effects as well as the exercise participation may differ according to the 
clinical picture. In inadequate doses and/or within certain FM subgroups, exercise may 
contribute to increased pain and other symptoms of FM
40,47,74,75
, likely followed by restrained 
activity level and energy expenditure. 
Based on the accessible information in the HUNT data, supplementary analyses 
investigated the distribution of comorbidities of athrosis, fatigue, insomnia, and functional 
restraining pain, illnesses or injuries within the current exercise subgroups. The prevalence of 
all these comorbidities were highest among the less active women, and thereby among women 
with highest BMI and WC, i.e., the differences in reported prevalence of the comorbidities 
range from 2.7% to 8.3% between the least and most active women with FM.   
These findings are in line with current researches. In addition to a relation between 
high BMI, and risk of and/or presence of pain and pain severity
13,14,34,35,46,60,61
, there are 
reported associations between presence of pain, and impaired psychological health
34,59
, poor 
sleep quality, reduced physical activity
59
, and lower quality of life
13
. Similar, a high BMI is 
associated with disturbed sleep
11,15
, physical impairment
11-13
, and low levels of physical 
activity
36
 and quality of life
13
. At the contrary, weight loss, partly attributed to physical 
exercise, is found to improve pain and comorbid symptoms of FM
16
. Further, well-adjusted 
exercise has shown to bring about improvement in pain
40,47,48
, functional status, and 
psychological and overall well-being
37,47-49
, as well as to be related to a more healthy body 
mass
38,39
. 
Thus, it is possible that the current exercise levels reflect different pathological 
subgroups, whereby the most physically active women with FM represent a subgroup which 
is less affected by comorbidities. Compared to the least active, they may then be less 
influenced of any additional adverse impact of comorbidities on body fat accumulation, 
exercise participation, and/or benefits of exercise. 
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Exercise effect between levels of chronic pain sites 
The curved relation between physical exercise, number of chronic pain sites, and body fat 
accumulation needs further elucidation. Women with ≥6 pain sites without FM may represent 
a subgroup with high prevalence of both known and unknown comorbidities, and with loss of 
body mass as a pathologic feature. Additional analyses with exclusions of other chronic 
diseases failed to identify a possible cause of the curved relation. An unmeasured, but relevant 
comorbidity in chronic pain states is cachexia, a wasting syndrome with detrimentally impact 
on several ongoing pathophysiologic processes
76-77
. Although the underlying 
pathophysiological mechanisms of cachexia are unclear, they likely involve disturbances in 
interplay among cytokines, neuropeptides, and neurotransmitters
76-77
. Unfortunately, no 
questions in the HUNT Study could be used to indicate whether prevalence of this or 
corresponding conditions were especially high among women with ≥6 pain sites. 
Another interpretation is a level off in the dose-response relation between body fat 
accumulation and chronic pain at the level of ≥6 pain sites. However, if FM represents the 
severe end of the spectrum of chronic musculoskeletal pain, this explanation is unlikely to be 
valid. Thus, the exact explanation of the curved relation needs further investigations. 
 
Strengths and limitations 
The current study has some strengths and limitations, which should be considered in the 
interpretation of the results. Although the study found strong associations between chronic 
musculoskeletal pain, FM, conditions of metabolic disturbances, BMI, and measures of 
abdominal fat layers, the cross-sectional design prevent drawing conclusions about 
directionalities and causations. Thus, prospective studies must be performed to elucidate any 
causality of the associations. 
The use of a large unselected population of adult women minimizes random errors, 
and the study sample is believed to represent a cross-section of the general female population 
in Norway. It is though not clear whether the results can be applied to other study populations 
differing in age, sex, or ethnicity. 
The use of self-administered questionnaires in assessing independent variables as FM, 
chronic musculoskeletal pain, DIA, and physical exercise, may induce personal 
misclassifications as it allows for subjective interpretation of the questions, including 
individual perception of the physical exercise
78
. The HUNT data do neither include 
assessment of different exercise types nor fitness components, which could, in addition to 
impact of occupational physical workload, be important in the interpretation of the 
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results
37,78,79
.  However, a validation study of the present physical exercise questionnaire 
showed that the “light” physical exercise question had poor reproducibility in a random 
sample of men, while the “hard” physical exercise question was found to be a useful measure 
of vigorous physical exercise in the same study population
79
. Likewise, the questions 
assessing chronic musculoskeletal pain have been shown to provide useful and reliable 
information on musculoskeletal symptoms
80
. However, none of the questionnaires are 
validated specific to the present study population of Norwegian women ≥20 years.  
The division into subgroups of increasing pain affliction and metabolic disturbances 
may indicate different cross-sections of a continuum and thereby strengthen the confidence of 
the findings. Nevertheless, limitations in the analyses must be acknowledged. The subdivision 
of physical exercise levels is a merger of a previous used subdivision in HUNT 2
45
, whereby 
the lowest activity level partly reflects WHO used boundary of insufficient activity in 
quantifying risk of health (i.e., <2.5 hours/week of light activity, <1 hour/week of vigorous 
activity)
17
. Nonetheless, attempt to investigate the effect of physical exercise on the 
associations between FM, metabolic disturbances, and measures of body fat accumulation 
failed, and the possibility of fallacious splitting cannot be ruled out.  
In spite of using important excluding criteria and despite adjustment for several factors 
related to FM, pain, metabolic disturbances, and/or body fat accumulation, adjustment for 
additional comorbidities would be important. Bias due to confounding by unmeasured or 
unknown factors, such as genetic predisposition and sociopsychological factors cannot be 
ruled out. The supplementary analyses of any impact on body fat distribution had no 
adjustments. On the other hand, the crude measures of BMI and abdominal fat layers showed 
similar trends as their corresponding multi-adjusted measures, which strengthen the likelihood 
of similar results also among multi-adjusted measures. 
 The capability to estimate total body fat
50,53
 and body fat distribution
50-52
 differ 
between different anthropometric measurements. Here, BMI was used as a measure of total 
body fat, whereas WC was used as a measure of abdominal fat layers. Similar analyses with 
WHR and WHtR resulted in the same trends as with WC, but none of them distinguish 
between the abdominal subcutaneous and visceral fat compartments. As discussed, the 
associations do not reflect the independent contribution of abdominal visceral fat layer. 
Similar misclassification of overall body fat is possible, as BMI has limitations like the 
difficulty to predict body composition (e.g., inability to take into account contributions of fat-
free mass versus fat mass)
50,53,55
. 
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Conclusion  
To summarize, there were dose-response associations between chronic musculoskeletal pain 
sites, FM, and levels of BMI and measures of abdominal fat layers. Physical exercise 
moderated these associations. However, the associations showed no differences in body fat 
distribution, as BMI and measures of abdominal fat layers increased in concurrence with each 
other among women with FM, DIA and/or GL ≥11.1 mmol/l, and FM and DIA and/or GL 
≥11.1 mmol/l together, referencing healthy women. Therefore, based on the current cross-
sectional study, the presences of chronic musculoskeletal pain and FM with or without 
metabolic comorbidities of DIA and/or GL ≥11.1 mmol/l are associated with increased BMI 
and measures of abdominal fat layers, whereby the accumulation of central fat seems to be 
dependent on concurrent overall body fat accumulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
REFERENCES 
1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al. 
The American College of Rheumatology 1990 criteria for the classification of 
fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 
1990;33:160-172. 
2. Russel J. Fibromyalgia syndrome. In: Mense S, Simons DG, editors. Muscle pain: 
understanding its nature, diagnosis, and treatment. Philadelphia: Lippincott Williams 
& Wilkins; 2001 p.289-337. 
3. Wilson HD, Robinson JP, Turk DC. Toward the identification of symptom patterns in 
people with fibromyalgia. Arthritis Rheum 2009;61:527-534. 
4. Kurtze N, Svebak S. Fatigue and patterns of pain in fibromyalgia: correlations with 
anxiety, depression and co-morbidity in a female county sample. Br J Med Psychol 
2001;74:523-537. 
5. Gupta A, Silman AJ. Psychological stress and fibromyalgia: a review of the evidence 
suggesting a neuroendocrine link. Arthritis Res Ther 2004;6:98-106. 
6. Okifuji A, Turk DC. Stress and psychological dysregulation in patients with 
fibromyalgia syndrome. Appl Psychophys Biof 2002;27:129-141. 
7. Staud R. Future perspectives: pathogenesis of chronic pain. Best Pract Res Clin 
Rheumatol 2007;21:581-596. 
8. Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of 
hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue 
syndrome. Ann N Y Acad Sci 1998;840:684-697. 
9. Martínez-Lavín M. Biology and therapy of fibromyalgia. Stress, the stress response 
system, and fibromyalgia. Arthritis Res Ther 2007;9:216-222. 
10. Martínez-Lavín M, Hermosillo AG, Rosas M, Soto ME. Circadian studies of 
autonomic nervous balance in patients with fibromyalgia: a heart rate variability 
analysis. Arthritis Rheum 1998;41:1966-1971. 
11. Okifuji A, Bradshaw DH, Olson C. Evaluating obesity in fibromyalgia: 
neuroendocrine biomarkers, symptoms, and functions. Clin Rheuma 2009;28:475-478. 
12. Yunus MB, Arslan S, Aldag JC. Relationship between body mass index and 
fibromyalgia features. Scand J Rheumatol 2002;31:27-31.  
13. Neumann L, Lerner E, Glazer Y, Bolotin A, Sherfer A, Buskila D. A cross-sectional 
study of the relationship between body mass index and clinical characteristics, 
25 
 
tenderness measures, quality of life, and physical functioning in fibromyalgia patients. 
Clin Rheuma 2008;27:1543-1547. 
14. Mork PJ, Vasseljen O, Nilsen TI. Association between physical exercise, body mass 
index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Trøndelag 
Health Study. Arthritis Care Res 2010;62:611-617. 
15. Brown WJ, Mishra G, Kenardy J, Dobson A. Relationships between body mass index 
and well-being in young Australian women. Int J Obes 2000;24:1360-1368. 
16. Shapiro JR, Anderson DA, Danoff-Brug S. A pilot study of the effects of behavioural 
weight loss treatment on fibromyalgia symptoms. J Psychosomat Res 2005;59:275-
282. 
17. World Health Organization. Reducing risks, promoting healthy life. World Health 
Organization. Geneva. The World Health Report; 2002. 
18. Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Publ Health 
2001;22:355-375. 
19. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, 
diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971. 
20. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY et al. 
Abdominal visceral and subcutaneous adipose tissue compartments. Association with 
metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. 
21. Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic 
complications. Ann N Y Acad Sci 2006;1083:77-110. 
22. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 
1997;13:795-803. 
23. Björntorp P. “Portal” adipose tissue as a generator of risk factors for cardiovascular 
disease and diabetes. Arteriosclerosis 1990;10:493-496. 
24. Björntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 
2001;2;73-86. 
25. Björntorp P, Rosmond R. Obesity and cortisol. Nutrition 2000;16:924-936. 
26. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953-966. 
27. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: 
peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 
2004;361:184-187. 
28. International Diabetes Federation. Promoting diabetes care, prevention and a cure 
worldwide. Brussels. International Diabetes Federation; 2006. 
26 
 
29. Loevinger BL, Muller D, Alonso C, Coe CL. Metabolic syndrome in women with 
chronic pain. Metab Clin Exp 2007;56:87-93. 
30. Tentolouris N, Liatis S, Katsilambrod N. Sympathetic system activity in obesity and 
metabolic syndrome. Ann N Y Acad Sci 2006;1083:129-152. 
31. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M et al. 
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: 
nested case-control study. Circulation 2002;106:2659-2665. 
32. Raison CL, Miller AH. When not enough is too much: the role of insufficient 
glucocorticoid signalling in the pathophysiology of stress-related disorders. Am J 
Psychiatry 2003;160:1554-1565. 
33. Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. 
Psychoneuroendocrino 2005;30:1010-1016. 
34. McCarty L, Bigal M, Katz M, Lipton R. Chronic pain and obesity in elderly people: 
results from the Einstein aging study. J Amer Geriat Soc 2009;57:115-119. 
35. Hitt HC, McMillen RC, Thornton-Neaves T, Koch K, Cosby AG. Comorbidity of 
obesity and pain in a general population: results from the Southern Pain Prevalence 
study. J Pain 2001;8:430-436. 
36. Petersen L, Schnohr P, Sørensen TI. Longitudinal study of the long-term relation 
between physical activity and obesity in adults. Int J Obes Relat Metab Disord 
2004;28:105-112. 
37. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the 
evidence. Can Med Assoc J 2006;174:801-809. 
38. Tremblay A, Després JP, Leblanc C, Craig CL, Ferris B, Stephens T et al. Effect of 
intensity of physical activity on body fatness and fat distribution. Am J Clin Nutr 
1990;51:153-157. 
39. Waller K, Kaprio J, Kujala UM. Associations between long-term physical activity, 
waist circumferences and weight gain: a 30-year longitudinal twin study. Int J Obes 
2008;32:353-361. 
40. Ortega E, García JJ, Bote ME, Martín-Cordero L, Escalante Y, Saavedra JM et al. 
Exercise in fibromyalgia and related inflammatory disorders: known effects and 
unknown changes. Exerc Immunol Rev 2009;15:42-65. 
41. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 
2005;98:1154-1162. 
27 
 
42. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. 
J Leuko Biol 2005;78:819-835. 
43. Das UN. Anti-inflammatory nature of exercise. Nutrition 2004;20:323-326. 
44. Goldsmith RL, Bloomfield DM, Rosenwinkel ET. Exercise and autonomic function. 
Coron Artery Dis 2000;11:129-135. 
45. Holth HS, Werpen HK, Zwart JA, Hagen K. Physical inactivity is associated with 
chronic musculoskeletal complaints 11 years later: results from the Nord-Trøndelag 
Health Study. BMC Musculoskelet Disord 2008;9:159.  
46. Nilsen TI, Holtermann A, Mork PJ. Physical exercise, body mass index, and risk of 
chronic pain in low back and neck/shoulders: longitudinal data from Norwegian 
HUNT study. Am J Epidemiol 2011 (In press). 
47. Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CI. Exercise for treating 
fibromyalgia syndrome. Cochrane Database Syst Rev 2007. 
48. Sim J, Adams N. Systematic review of randomized controlled trials of 
nonpharmacological interventions for fibromyalgia. Clin J Pain 2002;18:324-336. 
49. Rooks D, Gautam S, Romeling M, Cross ML, Stratigakis D, Evans B et al. Group 
exercise, education, and combination self-management in women with fibromyalgia. 
A randomized trial. Arc In Med 2007;167:2192-2200. 
50. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are 
particularly hazardous and how do we measure them? Int J Epidemiol 2006;35:83-92. 
51. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. 
Waist circumference and abdominal sagittal diameter: best simple anthropometric 
indexes of abdominal visceral adipose tissue accumulation and related cardiovascular 
risk in men and women. Amer J Cardiol 1994;73:460-468. 
52. Rankinen T, Kim SY, Pérusse L, Després JP, Bouchard C. The prediction of 
abdominal visceral fat layer from body composition and anthropometry: ROC 
analysis. Int J Obes 1999;23:801-809. 
53. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes 
2008;32:56-59. 
54. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L. Total and visceral adipose-
tissue volumes derived from measurements with computed tomography in adult men 
and women: predictive equations. Am J Clin Nutr 1988;48:1351-1361. 
55. Frankenfield DC, Rowe WA, Cooney RN, Smith JS, Becker D. Limits of body mass 
index to detect obesity and predict body composition. Nutrition 2001;17:26-30. 
28 
 
56. World Health Organization. Physical status: the use and interpretation of 
anthropometry. Report of WHO Expert Consultation. Geneva. WHO Technical Report 
Series; 1995. 
57. World Health Organization, International Diabetes Federation. Definition and 
diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of the 
WHO/IDF consultation. Geneva. World Health Organization; 2006. 
58. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. 
Hyperglycemia: an independent marker of in-hospital mortality in patients with 
undiagnosed diabetes. J Clin Endocr Metab 2002;87:978-982. 
59. Kamaleri Y, Natvig B, Ihlebaek CM, Benth JS, Bruusgaard D. Number of pain sites is 
associated with demographic, lifestyle, and health-related factors in the general 
population. Eur J Pain 2008;12:742-748. 
60. Lake JK, Powe C, Cole TJ. Back pain and obesity in the 1958 British birth cohort: 
cause or effect? J Clin Epidemiol 2000;53:245-250. 
61. Yusuf E, Nelissen RG, Ioan-Facsinay A, Stojanoviv-Susulic V, DeGroot J, van Osch 
G et al. Association between weight or body mass index and hand osteoarthritis: a 
systematic review. Ann Rheum Dis 2010;69:761-765. 
62. Yanmaz MN, Mert M, Korkmaz M. The prevalence of fibromyalgia syndrome in a 
group of patients with diabetes mellitus. Rheumatol Int 2011;Jan 08. [Epub ahead of 
print]. doi:10.1007/s00296-010-1618-8. 
63. Wang H, Moser M, Schiltenwolf M, Buchner M. Circulating cytokine levels compared 
to pain in patients with fibromyalgia. A prospective longitudinal study over 6 months. 
J Rheumatol 2008;35:1464-1474. 
64. Omoigui S. The biochemical origin of pain - proposing a new law of pain: the origin 
of all pain is inflammation and the inflammatory response. Part 1 of 3-a unifying law 
of pain. Med Hypoth 2007;69:70-82. 
65. Omoigui S. The biochemical origin of pain: the origin of all pain is inflammation and 
the inflammatory response. Part 2 of 3-inflammatory profile of pain syndromes. Med 
Hypoth 2007;69:1169-1178. 
66. Tchernof A, Bélanger C, Morisset AS, Richard C, Mailloux J, Laberge P et al. 
Regional differences in adipose tissue metabolism in women: minor effect of obesity 
and body fat distribution. Diabetes 2006;55:1353-1360. 
67. Lean ME, Han TS, Morrison CE. Waist circumference as measure for indicating need 
for weight management. Br Med J 1995;311:158-161. 
29 
 
68. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index 
explains obesity-related health risk. Am J Clin Nutr 2001;79:379-384. 
69. Turcato E, Bosello O, Di Francesco V, Harris TB, Zoico E, Bissoli L et al. Waist 
circumference and abdominal sagittal diameter as surrogates of body fat distribution in 
the elderly: their relation with cardiovascular risk factors. Int J Obes 2000;24:1005-
1010. 
70. Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW et al. 
Comparison of the associations of body mass index and measures of central adiposity 
and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study 
using data from 4 UK cohorts. Am J Clin Nutr 2001;20:547-556. 
71. Vazquez G, Duval S, Jacobs DR jr, Silventoinen K. Comparing of body mass index, 
waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-
analysis. Epidemiol Rev 2007;29:115-128. 
72. Qiao Q, Nyamdorj R. Is the association of type II diabetes with waist circumference or 
waist-to-hip ratio stronger than that with body mass index? Eur J Clin Nutr 
2010;64:30-34. 
73. Müller W, Schneider EM, Stratz T. The classification of fibromyalgia syndrome. 
Rheumatol Int 2007;27:1005-1010. 
74. Kosek E, Ekholm J, Hansson P. Modulation of pressure pain thresholds during and 
following isometric contraction in patients with fibromyalgia and in healthy controls. 
Pain 1996;64:415-423.  
75. Vierck CJ jr., Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD. The effect of 
maximal exercise on temporal summation of second pain (windup) in patients with 
fibromyalgia syndrome. J Pain 2001;2:334-344.  
76. Plata-Salamán CR. Central nervous system mechanisms contributing to the cachexia-
anorexia syndrome. Nutrition 2000;16:1009-1012. 
77. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical 
relevance. Am J Clin Nutr 2006;83:735-743. 
78. Vanhees L, Lefevre J, Philippaerts R, Martens M, Huygens W, Troosters T et al. How 
to assess physical activity? How to assess physical fitness? Eur J Cardiovasc Prev 
Rehabil 2005;12:102-114. 
79. Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-
reported physical activity in the Nord-Trøndelag Health Study (HUNT 2). Eur J 
Epidemiol 2007;22:379-387. 
30 
 
80. Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sørensen F, Andersson G et 
al. Standardised Nordic questionnaire for the analysis of musculoskeletal symptoms. 
Appl Ergon 1987;18:233-237. 
 
